Vitasora Health Limited (VHL) Fair Value & Analysis
Healthcare · AU · Market cap A$19.4M
Fair value as of: Jun 24, 2026
From 2 valuation models · updated 6 days ago
Share price +10.0% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.0106 – A$0.0508 · fair‑value band A$0.0200 – A$0.0300 · the A$0.0130 price screens below the A$0.0200 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Vitasora Health Limited (VHL) currently trades at A$0.0130, while our model-based Fair Value estimate is A$0.0200 — implying the stock looks roughly 53.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at A$5.0M. Revenue grew 84.5% year over year. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Vitasora Health Limited researches, develops, and commercializes medical devices in Australia and the United States. It is also involved in the production of mobile health applications. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Vitasora Health Limited reported revenue of A$3.7M in FY2025 versus A$270K in FY2021, a compound +92.5%/yr. Reported net income was −A$10.1M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $153.16 | $183.66 | +20% |
| Pro Medicus Limited PME | A$165.64 | A$28.02 | -83% |
| BrightSpring Health Services, Inc BTSG | $60.59 | $23.87 | -61% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $86.03 | $54.47 | -37% |
| M3, Inc MTHRY | $5.20 | $5.32 | +2% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Vitasora Health Limited (VHL) undervalued?
What is the fair value of VHL?
What is the quality score of VHL?
What is the revenue of Vitasora Health Limited (VHL)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.